Cardiovascular Disease in Saudi Arabia: Facts and the Way Forward

Adel A Tash1, Rasha F Al-Bawardy2,3

  • 1The National Heart Center at the Saudi Health Council, Riyadh, Saudi Arabia.

Insights

Cardiovascular diseases (CVDs) are a growing concern in Saudi Arabia due to lifestyle factors. This study reviews current CV health, proposes national registries, and digital solutions to reduce CVD burden and improve population health.

Area of Science:

  • Public Health
  • Health Economics
  • Cardiology

Background:

  • Cardiovascular diseases (CVDs) represent a significant global health challenge.
  • Key risk factors such as obesity, hypertension, type-2 diabetes, and dyslipidemia are increasing in Saudi Arabia, linked to sedentary lifestyles.
  • The Saudi Vision 2030 emphasizes reducing the clinical and economic burden of CVDs and enhancing public health.

Purpose of the Study:

  • To review the current cardiovascular health status and unmet needs in Saudi Arabia.
  • To examine primary prevention initiatives implemented by G20 countries.
  • To propose national registries and digital health solutions for improved CVD surveillance and management in Saudi Arabia.

Main Methods:

  • Literature review of current CV health and unmet needs in Saudi Arabia.
  • Analysis of primary prevention strategies from G20 nations.
  • Proposal for national registries and digital tools for population health research and surveillance.

Main Results:

  • Identifies rising CVD risk factors in Saudi Arabia.
  • Highlights the economic and clinical burden of CVDs on healthcare systems.
  • Discusses the potential of G20 prevention strategies and digital solutions for Saudi Arabia.

Conclusions:

  • Addressing modifiable CVD risk factors is crucial for reducing morbidity and mortality in Saudi Arabia.
  • Implementing national registries and digital health solutions can enhance CVD surveillance, research, and management.
  • A comprehensive healthcare approach is needed to alleviate the growing CVD burden and promote longevity in line with Saudi Vision 2030.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
24
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
13
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
366